Last10K.com

Artelo Biosciences, Inc. (ARTL) SEC Filing 8-K Material Event for the period ending Friday, March 1, 2019

Artelo Biosciences, Inc.

HISTORY TOOLS
CIK: 1621221 Ticker: ARTL

View differences made from one to another to evaluate Artelo Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Artelo Biosciences, Inc..

Continue

Assess how Artelo Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Artelo Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ARTL
CIK: 1621221
Form Type: 8-K Corporate News
Accession Number: 0001640334-19-000358
Submitted to the SEC: Wed Mar 06 2019 7:08:35 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Friday, March 1, 2019
Industry: Business Services
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/artl/0001640334-19-000358.htm